Ruben A. Mesa
Atrium Health Wake Forest Baptist(US)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes, Kruppel-like factors research
Most-Cited Works
- → Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis(2005)2,971 cited
- → A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis(2012)2,014 cited
- → Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study(2020)1,787 cited
- → New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment(2008)1,231 cited
- → Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis(2010)1,158 cited
- → MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients(2006)1,032 cited